person · Reporting owner

SIGAL ELLIOT

Disclosed activity across 3 companies

Tapewire entity: 16624
SEC CIK: 0001202294

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
BRISTOL MYERS SQUIBB COBMY · Entity 1662	Director · EVP, CSO & President R&D	June 03, 2013	June 05, 2013

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BRISTOL MYERS SQUIBB CO

Report date June 03, 2013 · Filed June 05, 2013

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $0.10 par valueSEC Table I · non-derivative	Direct	148,221	Ending reported balance After 2013-06-03 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2013-06-03 · Exercise / conversion · Acquired 98,875 · Balance 231,868 Row 2 · 2013-06-03 · Sale · Disposed 83,647 · Balance 148,221 F1: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $47.83 to $48.62, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Executive Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.01 · Expires 2017-03-05	Direct	25,000	Reported balance After 2013-06-03 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2013-06-03 · Exercise / conversion · Disposed 98,875 · Balance 25,000 F3: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007.
Common Stock, $0.10 par valueSEC Table I · non-derivative	IndirectBy BMY Savings & Investment Program	1,628.06	Reported balance Holding disclosure · report date 2013-06-03 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 1,628.06 F2: Based on a plan statement as of the end of the most recent fiscal quarter.
Common Stock, $0.10 par valueSEC Table I · non-derivative	IndirectBy C. Elliott Sigal 2012 Irrevocable Trust	18,180	Reported balance Holding disclosure · report date 2013-06-03 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 18,180
Common Stock, $0.10 par valueSEC Table I · non-derivative	IndirectBy Ruth L. Sigal Irrevocable Trust	18,180	Reported balance Holding disclosure · report date 2013-06-03 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 18,180
Common Stock, $0.10 par valueSEC Table I · non-derivative	IndirectBy Sigal Family Investments, LLC	9,091	Reported balance Holding disclosure · report date 2013-06-03 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 9,091

Filing footnotes · ownership attribution and instrument terms

F1: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $47.83 to $48.62, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F2: Based on a plan statement as of the end of the most recent fiscal quarter.

F3: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Mead Johnson Nutrition Co

Report date June 15, 2017 · Filed June 15, 2017

Section 16 reporting ended · disclosed 2017-06-15. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2017-06-15 transaction · row 1 1 source row Row 1 · 2017-06-15 · Disposition to issuer · Disposed 13,721 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
Common StockSEC Table I · non-derivative	IndirectBy Sigal Family Investments, LLC	Reported balance After 2017-06-15 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2017-06-15 · Disposition to issuer · Disposed 2,590 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
Common StockSEC Table I · non-derivative	IndirectBy the C. Elliott Sigal 2012 Irrevocable Trust	Reported balance After 2017-06-15 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2017-06-15 · Disposition to issuer · Disposed 5,180 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
Common StockSEC Table I · non-derivative	IndirectBy the Ruth L. Sigal 2012 Irrevocable Trust	Reported balance After 2017-06-15 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2017-06-15 · Disposition to issuer · Disposed 5,180 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2017-06-15 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2017-06-15 · Disposition to issuer · Disposed 1,709 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.

F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock.

F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.

Spark Therapeutics, Inc.

Report date December 17, 2019 · Filed December 17, 2019

Section 16 reporting ended · disclosed 2019-12-17. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2019-12-17 transaction · row 1 1 source row Row 1 · 2019-12-17 · Other · Disposed 14,214 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated February 22, 2019, by and between Spark Therapeutics, Inc. ("Spark"), Roche Holdings, Inc. ("Roche") and 022019 Merger Subsidiary, Inc. ("Merger Sub") (the "Merger Agreement" and the transactions contemplated thereby, the "Merger"), whereby Roche caused Merger Sub to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.001 per share, of Spark, at a price of $114.50 per share. On December 17, 2019, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $81.53 · Expires 2028-05-29	Direct	Reported balance After 2019-12-17 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-12-17 · Disposition to issuer · Disposed 4,000 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.93 · Expires 2027-05-30	Direct	Reported balance After 2019-12-17 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-12-17 · Disposition to issuer · Disposed 4,000 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.22 · Expires 2026-05-31	Direct	Reported balance After 2019-12-17 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-12-17 · Disposition to issuer · Disposed 6,000 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.45 · Expires 2024-08-11	Direct	Reported balance After 2019-12-17 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-12-17 · Disposition to issuer · Disposed 17,203 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.45 · Expires 2024-06-10	Direct	Reported balance After 2019-12-17 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-12-17 · Disposition to issuer · Disposed 25,786 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated February 22, 2019, by and between Spark Therapeutics, Inc. ("Spark"), Roche Holdings, Inc. ("Roche") and 022019 Merger Subsidiary, Inc. ("Merger Sub") (the "Merger Agreement" and the transactions contemplated thereby, the "Merger"), whereby Roche caused Merger Sub to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.001 per share, of Spark, at a price of $114.50 per share. On December 17, 2019, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn.

F2: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 29, 2013 Filed May 1, 2013 21:58 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	SaleCommon Stock, $0.10 par value	21,856	$39.90	$872,054.40	Disclosure SEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,955 F1 · shares: Includes shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. Read SEC document
April 29, 2013 Filed May 1, 2013 21:58 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	SaleCommon Stock, $0.10 par value	9,600	$40.00	$384,000.00	Disclosure SEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,811 F1 · shares: Includes shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. Read SEC document
April 29, 2013 Filed May 1, 2013 21:58 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	11,092	$24.74	$274,416.08	Disclosure SEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 29, 2013 Filed May 1, 2013 21:58 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	25,795	$22.73	$586,320.35	Disclosure SEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 29, 2013 Filed May 1, 2013 21:58 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	36,503	$24.74	$903,084.22	Disclosure SEC source: 0001225208-13-010911 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 10, 2013 Filed Mar 11, 2013 21:15 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GrantMarket Share Units · Derivative	29,630	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007266 · doc4.xml · derivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,630 Underlying: Common Stock, $0.10 par value · 29,630 shares Expires 2017-03-10 F1 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F2 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherPerformance Shares · Derivative	844.848	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 25 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,010.848 Underlying: Common Stock, $0.10 par value · 844.848 shares Expires 2015-03-31 F21 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2015. F22 · shares: Represents dividend equivalents earned under the 2012-2014 Long-Term Performance Award. F21 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2015. F21 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2015. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GrantPerformance Shares · Derivative	21,166	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 24 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,166 Underlying: Common Stock, $0.10 par value · 21,166 shares Expires 2015-03-31 F19 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2015. F20 · shares: Represents performance shares earned under the 2012-2014 Long-Term Performance Award. F19 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2015. F19 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2015. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherPerformance Shares · Derivative	2,465.8489	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 23 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,242.8489 Underlying: Common Stock, $0.10 par value · 2,465.8489 shares Expires 2014-03-31 F17 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F18 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. F17 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F17 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GrantPerformance Shares · Derivative	27,866	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 22 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,777 Underlying: Common Stock, $0.10 par value · 27,866 shares Expires 2014-03-31 F15 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F16 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. F15 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F15 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionPerformance Shares · Derivative	99,812	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 21 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 99,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F1 · shares: Represents distribution of performance shares earned under the 2010-2012 Long-Term Performance Award. F11 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F11 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherPerformance Shares · Derivative	3,832.0423	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 20 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,812 Underlying: Common Stock, $0.10 par value · 3,832.0423 shares Expires not disclosed F13 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F14 · shares: Represents dividend equivalents earned under the 2010-2012 Long-Term Performance Award. F13 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F13 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GrantPerformance Shares · Derivative	29,007	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 19 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,979.9577 Underlying: Common Stock, $0.10 par value · 29,007 shares Expires not disclosed F11 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F12 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award. F11 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F11 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionMarket Share Units · Derivative	8,801	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 18 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,406 Underlying: Common Stock, $0.10 par value · 8,801 shares Expires 2016-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionMarket Share Units · Derivative	12,062	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 17 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,491 Underlying: Common Stock, $0.10 par value · 12,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F2 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. F3 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F10 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionMarket Share Units · Derivative	11,715	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · derivative · entry 16 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,553 Underlying: Common Stock, $0.10 par value · 11,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F3 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F3 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F10 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	51,754	$37.53	$1,942,327.62	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 11 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,021 F7 · shares: Shares withheld for payment of taxes upon distribution of the 2010-2012 Long-Term Performance Award. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	9,343	$37.53	$350,642.79	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 10 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,775 F6 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	8,748	$37.53	$328,312.44	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,118 F6 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	5,194	$37.53	$194,930.82	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 8 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,866 F6 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherCommon Stock, $0.10 par value	1,216	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 7 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,060 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherCommon Stock, $0.10 par value	5,156	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 6 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,844 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherCommon Stock, $0.10 par value	5,957	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,688 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	8,801	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	11,715	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	12,062	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:50 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	99,812	$0.00	$0.00	Disclosure SEC source: 0001225208-13-007238 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2010-2012 Long-Term Performance Award. Read SEC document
March 04, 2013 Filed Mar 5, 2013 21:55 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionRestricted Stock Units · Derivative	7,453	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-13-006657 · doc4.xml · derivative · entry 10 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 7,453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 4, 2008. This is the final vesting of this award. F3 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 4, 2008. This is the final vesting of this award. Read SEC document
March 04, 2013 Filed Mar 5, 2013 21:55 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	3,865	$36.94	$142,773.10	Disclosure SEC source: 0001225208-13-006657 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,341 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document
March 04, 2013 Filed Mar 5, 2013 21:55 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	7,453	$0.00	$0.00	Disclosure SEC source: 0001225208-13-006657 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents vesting of one-third of restricted stock units granted on March 4, 2008. This is the final vesting of this award. Read SEC document
March 03, 2013 Filed Mar 5, 2013 21:55 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionRestricted Stock Units · Derivative	46,365	$0.00	$0.00	Disclosure SEC source: 0001225208-13-006657 · doc4.xml · derivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,367 Underlying: Common Stock, $0.10 par value · 46,365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. F1 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document
March 03, 2013 Filed Mar 5, 2013 21:55 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Tax withholdingCommon Stock, $0.10 par value	24,041	$37.15	$893,123.15	Disclosure SEC source: 0001225208-13-006657 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,753 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document
March 03, 2013 Filed Mar 5, 2013 21:55 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	46,365	$0.00	$0.00	Disclosure SEC source: 0001225208-13-006657 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document
February 08, 2013 Filed Feb 11, 2013 21:08 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionOption (right to buy) · Derivative	48,333	$0.00 Strike: $28.11	$0.00	Disclosure SEC source: 0001225208-13-003595 · doc4.xml · derivative · entry 11 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 48,333 shares Expires 2014-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 2, 2004. Read SEC document
February 08, 2013 Filed Feb 11, 2013 21:08 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionExecutive Option (right to buy) · Derivative	70,000	$0.00 Strike: $22.73	$0.00	Disclosure SEC source: 0001225208-13-003595 · doc4.xml · derivative · entry 10 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,795 Underlying: Common Stock, $0.10 par value · 70,000 shares Expires 2016-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2006. Read SEC document
February 08, 2013 Filed Feb 11, 2013 21:08 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionExecutive Option (right to buy) · Derivative	147,749	$0.00 Strike: $17.51	$0.00	Disclosure SEC source: 0001225208-13-003595 · doc4.xml · derivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 147,749 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 3, 2009. Read SEC document
February 08, 2013 Filed Feb 11, 2013 21:08 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	SaleCommon Stock, $0.10 par value	224,705	$36.79	$8,266,896.95	Disclosure SEC source: 0001225208-13-003595 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,429 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.73 to $36.93, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document
February 08, 2013 Filed Feb 11, 2013 21:08 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	48,333	$28.11	$1,358,640.63	Disclosure SEC source: 0001225208-13-003595 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 08, 2013 Filed Feb 11, 2013 21:08 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	70,000	$22.73	$1,591,100.00	Disclosure SEC source: 0001225208-13-003595 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 08, 2013 Filed Feb 11, 2013 21:08 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionCommon Stock, $0.10 par value	147,749	$17.51	$2,587,084.99	Disclosure SEC source: 0001225208-13-003595 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 11, 2012 Filed Dec 13, 2012 21:28 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	SaleCommon Stock, $0.10 par value	62,903	$33.00	$2,075,799.00	Disclosure SEC source: 0001181431-12-064463 · rrd363264.xml · nonDerivative · entry 7 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By Ruth L. Sigal 2012 Irrevocable Trust Disclosed balance after: 37,412 F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.81 to $33.23, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document
December 11, 2012 Filed Dec 13, 2012 21:28 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	SaleCommon Stock, $0.10 par value	62,903	$33.00	$2,075,799.00	Disclosure SEC source: 0001181431-12-064463 · rrd363264.xml · nonDerivative · entry 6 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By C. Elliott Sigal 2012 Irrevocable Trust Disclosed balance after: 37,412 F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.81 to $33.23, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document
December 11, 2012 Filed Dec 13, 2012 21:28 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	SaleCommon Stock, $0.10 par value	31,451	$33.00	$1,037,883.00	Disclosure SEC source: 0001181431-12-064463 · rrd363264.xml · nonDerivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By Sigal Family Investments, LLC Disclosed balance after: 18,707 F5 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.81 to $33.23, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document
November 27, 2012 Filed Dec 13, 2012 21:28 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GiftCommon Stock, $0.10 par value	100,315	$0.00	$0.00	Disclosure SEC source: 0001181431-12-064463 · rrd363264.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By Ruth L. Sigal 2012 Irrevocable Trust Disclosed balance after: 100,315 F3 · shares: On November 27, 2012, the reporting person's wife contributed her 40% interest in SFI to the Ruth L. Sigal 2012 Irrevocable Trust for the benefit of the reporting person and their children. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: On November 27, 2012, the reporting person's wife contributed her 40% interest in SFI to the Ruth L. Sigal 2012 Irrevocable Trust for the benefit of the reporting person and their children. Read SEC document
November 27, 2012 Filed Dec 13, 2012 21:28 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GiftCommon Stock, $0.10 par value	100,315	$0.00	$0.00	Disclosure SEC source: 0001181431-12-064463 · rrd363264.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By C. Elliott Sigal 2012 Irrevocable Trust Disclosed balance after: 100,315 F2 · shares: On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. F2 · ownership.nature: On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI. Read SEC document
November 27, 2012 Filed Dec 13, 2012 21:28 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GiftCommon Stock, $0.10 par value	200,630	$0.00	$0.00	Disclosure SEC source: 0001181431-12-064463 · rrd363264.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Indirect · By Sigal Family Investments, LLC Disclosed balance after: 50,158 F1 · shares: On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI. F2 · shares: On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI. F3 · shares: On November 27, 2012, the reporting person's wife contributed her 40% interest in SFI to the Ruth L. Sigal 2012 Irrevocable Trust for the benefit of the reporting person and their children. F1 · balance_after: On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI. F2 · balance_after: On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI. F1 · ownership.direct: On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI. F1 · ownership.nature: On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI. Read SEC document
September 05, 2012 Filed Sep 7, 2012 20:06 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherCommon Stock, $0.10 par value	250,788	$0.00	$0.00	Disclosure SEC source: 0001225208-12-019250 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,840 F1 · kind: On September 5, 2012, the reporting person transferred to his wife a 40% pecuniary interest in 250,788 shares of Bristol-Myers Squibb common stock. For purposes of clarity, while the transfer is shown as a disposition, the transfer did not increase or decrease the number of shares reported as beneficially owned by the reporting person. F1 · shares: On September 5, 2012, the reporting person transferred to his wife a 40% pecuniary interest in 250,788 shares of Bristol-Myers Squibb common stock. For purposes of clarity, while the transfer is shown as a disposition, the transfer did not increase or decrease the number of shares reported as beneficially owned by the reporting person. F1 · price: On September 5, 2012, the reporting person transferred to his wife a 40% pecuniary interest in 250,788 shares of Bristol-Myers Squibb common stock. For purposes of clarity, while the transfer is shown as a disposition, the transfer did not increase or decrease the number of shares reported as beneficially owned by the reporting person. F1 · balance_after: On September 5, 2012, the reporting person transferred to his wife a 40% pecuniary interest in 250,788 shares of Bristol-Myers Squibb common stock. For purposes of clarity, while the transfer is shown as a disposition, the transfer did not increase or decrease the number of shares reported as beneficially owned by the reporting person. F2 · ownership.direct: On September 7, 2012, the reporting person and his wife contributed their combined interest in the 250,788 shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. The reporting person is the sole manager of SFI. The contribution of the shares to SFI effects only a change in the form of the reporting person's beneficial ownership of securities, without increasing or decreasing his pecuniary interest in the securities or transferring a pecuniary interest to another person, and is exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13. The reporting person's indirect ownership in the shares contributed to SFI will be reflected on the reporting person's next Section 16 report covering non-derivative securities. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	Exercise / conversionRestricted Stock Units · Derivative	6,875	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 13 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F20 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F2 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. F2 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	OtherPerformance Shares · Derivative	1,457	$0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 12 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,911 Underlying: Common Stock, $0.10 par value · 1,457 shares Expires 2014-03-31 F18 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F19 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. F18 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F18 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document
March 06, 2012 Filed Mar 9, 2012 02:27 UTC	BRISTOL MYERS SQUIBB CO BMY · Entity 1662	GrantPerformance Shares · Derivative	32,454	$0.00	$0.00	Disclosure SEC source: 0001225208-12-007115 · doc4.xml · derivative · entry 11 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,454 Underlying: Common Stock, $0.10 par value · 32,454 shares Expires 2014-03-31 F16 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F17 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. F16 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F16 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.